Abstract
MicroRNAs (miRNAs) are crucial in the initiation and progression of tumors. A recent study has reported that the miRNAs miR-221 and miR-222 are involved in the promotion of an aggressive basal-like phenotype in breast cancer, functioning downstream of the RAS pathway and triggering epithelial-to-mesenchymal transition. These new insights into the roles of miR-221/222 in breast cancer metastasis, drug resistance and RAS pathways could potentially have applications in medical practice. © 2011 BioMed Central Ltd.
Cite
CITATION STYLE
Shah, M. Y., & Calin, G. A. (2011, August 31). MicroRNAs miR-221 and miR-222: A new level of regulation in aggressive breast cancer. Genome Medicine. https://doi.org/10.1186/gm272
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.